(AGENPARL) – SEATTLE (WASHINGTON) mer 19 aprile 2023 Mobility is entering a new age of innovation. We examined regional trends…

(AGENPARL) – SEATTLE (WASHINGTON) mer 19 aprile 2023 Options for traveling from point A to point B often depend on…

(AGENPARL) – SEATTLE (WASHINGTON) mer 19 aprile 2023 Mobility is on the verge of a major transformation, but those shifts…

(AGENPARL) – mer 19 aprile 2023 Update from GOV.?UK for: News and communications Defence Secretary meets US defence and security…

(AGENPARL) – SILVER SPRING mer 19 aprile 2023 Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of…

(AGENPARL) – WEST LAFAYETTE (U.S.) mer 19 aprile 2023 Purdue University West Lafayette ID Card Operations/Support, in partnership with Student Life…

(AGENPARL) – SILVER SPRING mer 19 aprile 2023 COVID-19: Developing Drugs and Biological Products for Treatment or Prevention Fonte/Source: http://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-developing-drugs-and-biological-products-treatment-or-prevention

(AGENPARL) – SILVER SPRING mer 19 aprile 2023 CDER is engaged in numerous activities to protect and promote public health during…

(AGENPARL) – WASHINGTON mer 19 aprile 2023 Inflation remains the top concern for a majority of small business owners (54%) according…

(AGENPARL) – mer 19 aprile 2023 Update from GOV.?UK for: News and communications Fulfilling the promise of the Belfast (Good…